Sanofi (SNY)
NASDAQ: SNY · Real-Time Price · USD
45.95
+0.05 (0.11%)
At close: Apr 28, 2026, 4:00 PM EDT
46.12
+0.17 (0.37%)
After-hours: Apr 28, 2026, 7:40 PM EDT
Sanofi Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Sanofi stock has a target of 58, which predicts an increase of 26.22% from the current stock price of 45.95.
Analyst Consensus: Buy
* Price targets were last updated on Sep 8, 2025.
Analyst Ratings
The average analyst rating for Sanofi stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 3 | 4 | 4 | 4 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 6 | 6 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jan 16, 2026 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 9, 2025 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Dec 8, 2025 |
| Morgan Stanley | Morgan Stanley | Hold → Buy Upgrades $56 → $58 | Hold → Buy | Upgrades | $56 → $58 | +26.22% | Sep 8, 2025 |
| Deutsche Bank | Deutsche Bank | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Sep 2, 2025 |
Financial Forecast
Revenue This Year
48.35B
from 46.72B
Increased by 3.49%
Revenue Next Year
51.29B
from 48.35B
Increased by 6.10%
EPS This Year
8.57
from 6.37
Increased by 34.38%
EPS Next Year
9.08
from 8.57
Increased by 6.04%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 52.5B | 55.9B | ||||||
| Avg | 48.3B | 51.3B | ||||||
| Low | 44.9B | 47.3B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 12.4% | 15.6% | ||||||
| Avg | 3.5% | 6.1% | ||||||
| Low | -4.0% | -2.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 9.31 | 10.31 | ||||||
| Avg | 8.57 | 9.08 | ||||||
| Low | 7.59 | 7.85 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 46.1% | 20.4% | ||||||
| Avg | 34.4% | 6.0% | ||||||
| Low | 19.1% | -8.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.